1558 — Yichang Hec Changjiang Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- HK$13.97bn
- HK$14.88bn
- CNY3.72bn
Annual income statement for Yichang Hec Changjiang Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,348 | 914 | 3,745 | 6,295 | 3,724 |
| Cost of Revenue | |||||
| Gross Profit | 1,997 | 484 | 2,846 | 4,986 | 2,794 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,093 | 1,337 | 3,424 | 3,940 | 3,049 |
| Operating Profit | 1,255 | -423 | 321 | 2,354 | 674 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1,010 | -667 | 39.4 | 2,127 | 577 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 837 | -588 | 49.2 | 1,856 | 483 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 839 | -588 | 76.6 | 1,993 | 483 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 590 | -588 | 76.6 | 1,993 | 483 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.538 | -0.635 | 0.301 | 2.75 | 0.621 |
| Dividends per Share | |||||
| Special Dividends per Share |